Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism

Marcus Tan, Chelsea A. Isom, Yangzi Liu, David‐Alexandre Trégouët, Sara Lindström, Lu Wang, Erin N. Smith, William Gordon, Astrid van Hylckama Vlieg, Mariza De Andrade, Jennifer A. Brody, Jack Pattee, Jeffrey Haessler, Ben Brumpton, Daniel I. Chasman, Pierre Suchon, Ming‐Huei Chen, Constance Turman, Marine Germain, Kerri L. Wiggins, James MacDonald, Sigrid K. Brækkan, Sebastian M. Armasu, Nathan Pankratz, Rabecca D Jackson, Jonas B. Nielsen, Franco Giulianini, Marja Puurunen, Manal Ibrahim, Susan R. Heckbert, Theo K. Bammler, Kelly A. Frazer, Bryan M. McCauley, Kent D. Taylor, James S. Pankow, Alexander P. Reiner, Maiken E. Gabrielsen, Jean‐François Deleuze, Christopher J. O’Donnell, Jihye Kim, Barbara McKnight, Peter Kraft, J.-B. Hansen, Frits R. Rosendaal, John A. Heit, Bruce M. Psaty, Weihong Tang, Charles Kooperberg, Kristian Hveem, Paul M. Ridker, Pierre‐Emmanuel Morange, Andrew M. Johnson, Christopher Kabrhel, David‐Alexandre Trégouët, Nicholas H. Smith, Lang Wu, Dan Zhou, Eric R. Gamazon (2024). Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism. EBioMedicine, 106, pp. 105233-105233, DOI: 10.1016/j.ebiom.2024.105233.